Fritz Ott

Title: The Innovative Contributions of Fritz Ott

Introduction

Fritz Ott is a notable inventor based in Oberrieden, Switzerland. He has made significant contributions to the field of medicine, particularly in the treatment of cell-mediated immune diseases. With a total of 2 patents to his name, his work has the potential to impact many patients suffering from chronic conditions.

Latest Patents

Fritz Ott's latest patents focus on the treatment of cell-mediated immune diseases using 9-cis retinoic acid and its derivatives. One patent describes the efficacy of 9-cis retinoic acid, along with pharmaceutically acceptable salts and hydrolyzable esters, in treating T-helper cell type 1 mediated immune diseases. The active ingredient is preferably formulated as a medicament for oral or topical administration. Another patent outlines a method for treating chronic hand eczema in patients through the oral administration of 9-cis retinoic acid in effective doses ranging from 0.05 to 1.5 milligrams per kilogram of body weight per day.

Career Highlights

Throughout his career, Fritz Ott has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Basilea Pharmaceutica AG and Glaxo Group Limited. His experience in these organizations has contributed to his expertise in developing innovative treatments.

Collaborations

Fritz Ott has collaborated with various professionals in his field, including his coworker Werner Bollag. These collaborations have likely enhanced his research and development efforts, leading to his successful patent applications.

Conclusion

Fritz Ott's contributions to the treatment of immune diseases through his innovative patents demonstrate his commitment to advancing medical science. His work continues to pave the way for new therapeutic options for patients in need.